New hope for tough HPV cancers? early trial tests TGN-S11
Disease control
Completed
This early-phase trial tested an experimental drug called TGN-S11 in 28 adults with HPV-related cancers that had come back or spread. The main goal was to find a safe dose and see if the drug could help control the disease. Some participants also received a second drug to boost t…
Phase: PHASE1 • Sponsor: Toragen, Inc. • Aim: Disease control
Last updated May 12, 2026 13:42 UTC